aTYR PHARMA (ATYR) Amortizatization of Intangibles (2014 - 2026)

aTYR PHARMA (ATYR) has 13 years of Amortizatization of Intangibles data on file, last reported at $255000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 51.24% year-over-year to $255000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 34.38% YoY) and the FY2025 annual result came in at $1.9 million, down 31.46% from the prior year.
• Amortizatization of Intangibles eased to $255000.0 in Q1 2026, from $361000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $977000.0 in Q3 2023 to a low of -$237000.0 in Q1 2022.
• A 5-year average of $438352.9 and a median of $512000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 364.71% — and 2023, when it soared 2690.62%.
• Tracing ATYR's Amortizatization of Intangibles over 5 years: stood at $32000.0 in 2022, then soared by 2690.62% to $893000.0 in 2023, then plunged by 38.41% to $550000.0 in 2024, then plunged by 34.36% to $361000.0 in 2025, then slipped by 29.36% to $255000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $255000.0 (Q1 2026), $361000.0 (Q4 2025), and $512000.0 (Q3 2025), per Business Quant data.